Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Return on Capital Employed (2020 - 2021)

Historic Return on Capital Employed for Black Diamond Therapeutics (BDTX) over the last 2 years, with Q3 2021 value amounting to 0.44%.

  • Black Diamond Therapeutics' Return on Capital Employed fell 2700.0% to 0.44% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.44%, marking a year-over-year decrease of 2700.0%. This contributed to the annual value of 0.3% for FY2020, which is 100.0% down from last year.
  • As of Q3 2021, Black Diamond Therapeutics' Return on Capital Employed stood at 0.44%, which was down 2700.0% from 0.33% recorded in Q2 2021.
  • Black Diamond Therapeutics' 5-year Return on Capital Employed high stood at 0.13% for Q2 2020, and its period low was 0.44% during Q3 2021.